Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 5134602, 8 pages
Research Article

The Use of Antidepressants, Anxiolytics, and Hypnotics in People with Type 2 Diabetes and Patterns Associated with Use: The Hoorn Diabetes Care System Cohort

1EMGO+ Institute for Health and Care Research, VU Medical Center, Amsterdam, Netherlands
2Department of Clinical Pharmacology and Pharmacy, VU Medical Center, Amsterdam, Netherlands
3Department of Epidemiology and Biostatistics, VU Medical Center, Amsterdam, Netherlands
4Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands
5Department of General Practice and Elderly Care Medicine, VU Medical Center, Amsterdam, Netherlands
6Department of Psychiatry, VU Medical Center, Amsterdam, Netherlands

Correspondence should be addressed to R. Mast; ln.cmuv@tsam.m

Received 21 August 2016; Accepted 27 December 2016; Published 23 January 2017

Academic Editor: Jessica J. Jalbert

Copyright © 2017 R. Mast et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Short description Supplementary material:

The New Hoorn Study is a population-based cohort, which is representative for the general Dutch population. Of the eligible participants, 45% agreed to participate, resulting in a population-based cohort of 2807 participants. As this population-based cohort is sampled from the general population within the catchment area of the Diabetes Care System Cohorts, is about the same age, adheres to the same level of care, and shares a study location, nurses, and study protocols, we believe it is the optimal comparison cohort.

In short, this population-based cohort was aged 53.4 ± 6.7 years; similarly to the T2DM cohort about 50% was male, and, however, as it is a population-based cohort only 7.1% had prevalent diabetes according to the WHO criteria.

  1. Supplementary Material